Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

5-Amino-1MQ Dosage Guide, Benefits & Side Effects

5-Amino-1MQ Dosage Guide, Benefits & Side Effects 5-Amino-1MQ blocks NNMT to raise NAD+ and shift metabolism toward fat oxidation. See preclinical dosing, mechanism, and body composition research. As seen on 5-Amino-1MQ Dosage Guide for Weight + Fat Loss5-Amin

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

5-Amino-1MQ Dosage Guide, Benefits & Side Effects

5-Amino-1MQ blocks NNMT to raise NAD+ and shift metabolism toward fat oxidation. See preclinical dosing, mechanism, and body composition research.

As seen on

5-Amino-1MQ Dosage Guide for Weight + Fat Loss5-Amino-1MQ Dosage Calculator

5-Amino-1MQ supports mitochondrial function and can help with fat loss.

Vial size

25 mg

Bacteriostatic water

3 mL

Dosing

1–5 mg

Frequency

Daily

Cycle

16+ weeks

Benefit

Weight + Fat Loss

What is 5-Amino-1MQ?

5-Amino-1MQ is a lab-made compound (not actually a peptide, despite being listed as one) that blocks an enzyme called NNMT, which normally drains a molecule your cells need for energy (NAD+) and slows your metabolism down. By blocking that enzyme, it may help raise energy levels and shift the body toward burning fat instead of storing it. It's still early-stage, studied mostly in lab and animal settings, for weight management, metabolic health, and healthy aging.

Weight

Research targets include appetite regulation, fat metabolism, and body composition.

Longevity

Research targets include cellular aging, senescence, and long-term healthspan.

Metabolic

Research targets include glucose regulation, insulin sensitivity, and energy metabolism.

5am

Is 5-Amino-1MQ FDA approved?

5-Amino-1MQ is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

5-Amino-1MQ has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does 5-Amino-1MQ Work?

It blocks an enzyme (NNMT) that would otherwise drain a cell's NAD+, a molecule cells need for energy production. With more NAD+ available, a chain of energy-sensing switches (SIRT1, PGC-1α) turns on, prompting cells to build more mitochondria and burn more fat for fuel.

Blocks NNMT

Inhibits an enzyme that normally drains NAD+ from cells.

NAD+ rises

More NAD+ activates energy-sensing switches like SIRT1 and PGC-1α.

More fat burned

Cells build new mitochondria and shift toward burning fat for fuel.

5-Amino-1MQ Targeted areas

How to reconstitute 5-Amino-1MQ

The materials you'll need and step-by-step instructions for safely mixing 5-Amino-1MQ with bacteriostatic water.

Materials needed

Your 5-Amino-1MQ vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the 5-Amino-1MQ vial

With the bac water in your syringe, insert the needle into the 5-Amino-1MQ vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store 5-Amino-1MQ

Keep the dry powder in the freezer, where it lasts about two years. Once you mix it with liquid, keep it in the fridge and use it up within 2–4 weeks. Keep it out of light and don't freeze it again after mixing.

Lyophilized Storage

Store at -20°C, stable up to 24 months.

Reconstituted Storage

Refrigerate at 2–8°C and use within 2–4 weeks.

Handling Notes

Keep away from light; do not refreeze after reconstitution.

What Are the Benefits of 5-Amino-1MQ?

What research says it may help with, and how it works in the body.

longevity

Helps cells build more and better-functioning mitochondria (their energy-producing parts), boosting energy production and lowering signs of cell damage linked to aging.

Having more NAD+ available helps activate sirtuins and other biological systems linked to longevity, supporting DNA repair, cell upkeep, and resistance to stress.

Significantly raises levels of NAD+, a molecule cells need for energy, by blocking an enzyme called NNMT. This supports energy production and DNA repair that are important for healthy aging.

metabolism

Helps the body's metabolism work better by making the energy-producing parts of cells (mitochondria) more efficient.

Boosts metabolism by helping cells use energy more efficiently.

Helps the body switch more easily between burning sugar and burning fat for fuel.

weight loss

Helps the body burn fat more effectively.

Helps increase the rate at which the body burns calories at rest.

What Are the Side Effects of 5-Amino-1MQ?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Pregnancy or breastfeeding

Pre-existing metabolic conditions (consult healthcare provider)

Stop Right Away If You Notice

Severe gastrointestinal upset or persistent nausea

Unusual fatigue or weakness (opposite of expected effect)

Persistent headaches or dizziness

Sleep disturbances or insomnia

Allergic reactions (rash, swelling, difficulty breathing)

Significant mood changes or anxiety

Milder Signs to Watch For

Peptides Commonly Stacked With 5-Amino-1MQ

Peptides that are commonly stacked with 5-Amino-1MQ, and the blends that combine them.

Mito Prime

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)

Preclinical

How Long Should a 5-Amino-1MQ Cycle Last?

This breaks down how long a typical 5-Amino-1MQ cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

aod

AOD-9604

Experimental

bam

BAM-15

cag

Cagrilintide

Phase 3

mot

MOTS-c

Phase 1

Cheat Sheets Featuring 5-Amino-1MQ

See how 5-Amino-1MQ fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

42 peptides

78 peptides

14 peptides

19 peptides

5-Amino-1MQ Research References

It is a preclinical compound

5-Amino-1MQ

5-Amino-1MQ is a preclinical compound

Demonstrated 38.4% oral bioavailability, half-life 6.9hr (oral) and 3.8hr (IV). Supports oral administration viability.

2021

Diet-induced obese mice showed 5.1% weight loss, 30% adipocyte size reduction at 60mg/kg/day. Human equivalent ~5mg/kg/day using FDA allometric scaling.

2018

40% grip strength improvement in sedentary mice, 60% with exercise at 10mg/kg/day SubQ for 8 weeks. No adverse effects observed.

2024

Frequently Asked Questions About 5-Amino-1MQ

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is 5-Amino-1MQ and how does it work?

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small, cell-permeable molecule studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme found in fat and other tissue that normally consumes SAM (S-adenosylmethionine) and reduces cellular NAD+ availability. By blocking NNMT, 5-Amino-1MQ is thought to raise intracellular NAD+ and SAM levels and reactivate pathways like SIRT1 and AMPK that support mitochondrial function and a shift toward fat oxidation. Despite being marketed alongside peptides, it is chemically a small-molecule quinolinium compound rather than a true amino-acid chain peptide.

What is 5-Amino-1MQ used for in research, and is there human evidence it works?

It is primarily studied for potential effects on fat mass, body weight, and metabolic markers. The main supporting evidence comes from rodent studies (including a widely cited 2019 Nature Communications paper) showing increased energy expenditure and reduced fat mass in mice given NNMT inhibitors, without changes in food intake. As of 2026, there are no published human clinical trials, no FDA-approved indication, and no data confirming these effects translate to people, so any human benefit remains unproven and speculative.

What dosage and administration protocols do people commonly discuss?

Community and vendor protocols vary widely and are not clinically validated. Commonly cited ranges run from roughly 25–150 mg per day, often split into twice-daily oral dosing because the compound's reported half-life (roughly 4–7 hours) is fairly short. Cycles of about 8–12 weeks on, with several weeks off, are frequently mentioned. It is typically taken orally (it does not require reconstitution the way injectable peptides do), though some research protocols reconstitute it for subcutaneous use. Because there is no established human dosing standard, these figures reflect informal practice, not medical guidance.

What side effects are reported with 5-Amino-1MQ?

User reports and vendor/blog sources most commonly mention mild gastrointestinal discomfort or nausea, headache, and fatigue, with these effects appearing more frequently at higher doses. Some sources also mention appetite suppression and, less commonly, mild hypoglycemia-like symptoms. Long-term human safety data does not exist, and the longest available studies are limited animal studies (12–16 weeks), so the full side-effect profile in humans, including any risks with extended use, is not well characterized.

Is 5-Amino-1MQ legal to buy, and is it FDA-approved?

5-Amino-1MQ is not FDA-approved for any medical use and has no registered human clinical trials. In the United States it is generally sold as an unregulated 'research chemical' or 'research use only' compound, meaning it can be legally manufactured and sold for laboratory research, but it is not legal to market for human consumption or to make health/medical claims about it. It is also not included on the FDA's list of bulk substances approved for compounding pharmacies. Regulations vary by country, so legal status elsewhere may differ.

How should 5-Amino-1MQ be stored?

For lyophilized (powder) forms sold for reconstitution, common guidance is to store the unreconstituted powder frozen (around -20°C) and, once reconstituted with bacteriostatic water, to refrigerate it (roughly 2-8°C) and use it within about 2-4 weeks. Oral capsule or tablet forms are generally stored per standard supplement guidance (cool, dry, away from light). As with any research compound, exact stability data is limited, so vendor-specific instructions should be followed.

Is 5-Amino-1MQ commonly stacked with other compounds like GLP-1 drugs?

Yes, it is frequently discussed alongside GLP-1 receptor agonists such as semaglutide or tirzepatide in online research communities, on the reasoning that the two work through non-overlapping mechanisms: GLP-1 drugs primarily reduce appetite and caloric intake, while 5-Amino-1MQ is proposed to act on cellular fat-oxidation pathways via NNMT inhibition. This combination is based on theoretical complementarity and anecdotal use rather than any controlled human trial data demonstrating added benefit or safety.

Is 5-Amino-1MQ safe, and should it be used without medical supervision?

Because 5-Amino-1MQ has no published human trials, its safety profile in people is not established. Sources uniformly note it should not be treated as a proven or approved therapy, is not recommended during pregnancy or breastfeeding, and that any use carries unknown long-term risk. Products sold for research purposes are explicitly not intended for human consumption, and individuals considering use should be aware this falls outside standard medical and regulatory oversight.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching 5-Amino-1MQ — share findings, ask questions, and learn from real experiences 5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function. Not a true peptide, but a small molecule compound used in longevity and metabolic optimization protocols. Inhibits NNMT enzyme systemically, preventing NAD+ degradation and maintaining elevated cellular NAD+ levels to support mitochondrial function and metabolic processes.

Source: peptide-db.com ↗

Research review and sources

Reviewed by: PeptideUniv Updated: March 26, 2026 Human trial evidence exists, but the practical takeaways still depend on population, endpoint, and how long the compound has been studied. Key research takeaways surfaced on this page Research context available in the underlying profile. Primary references and supporting sources Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction — Recent 5A1MQ preclinical paper covering obesity, glucose, and liver outcomes. Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome — Review article that explains the rationale for targeting NNMT in metabolic research.

Source: peptideuniv.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

5-Amino-1MQ Dosage Protocols

Standard Fat Loss Protocol 50 mg Once daily with food 8-12 weeks Accelerated Protocol 100 mg/day (50 mg twice daily) Twice daily with meals Metabolic Stack Protocol 50-100 mg/day oral Once or twice daily Standard Fat Loss Protocol: Start here to assess tolerance. Take with breakfast or lunch. Avoid taking late in the day on the off chance it affects sleep (rare but reported). Most users see gradual results starting around week 4. Accelerated Protocol: Split the dose between breakfast and lunch. This is the upper range commonly used. Do not exceed 100 mg/day without medical guidance. Better results when combined with regular exercise and a moderate caloric deficit. Metabolic Stack Protocol: When stacking with MOTS-c or a GLP-1 agonist, start at 50 mg/day and increase only if well tolerated. The combination targets multiple metabolic pathways simultaneously, so starting conservatively is wise. These are general guidelines for research purposes. Always consult a healthcare professional before use.

Source: peptidesexplorer.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →